BROWSE ALL ARTICLES BY TOPIC
Articles by Section - Regular Article
Listing articles 21 to 30 of 405
Features: Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection
Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously
News: Rheumatology Chooses Wisely
ACR identifies five practices, therapies, or procedures physicians and patients should question
Features: How to Evaluate Shoulder Pain
The common causes of shoulder pain and diagnostic tests that rheumatologists need to know
Meeting: ACR/ARHP Annual Meeting 2012: How Rheumatologists Can Negotiate Better Contracts with Payers
Improving contracts with payers can earn rheumatologists more money, with no added costs in staffing or equipment
Meeting: ACR/ARHP Annual Meeting 2012: Understanding Pain Signals May Pave Path to More Effective Therapies
The ability to differentiate the types of pain affiliated with rheumatic diseases can help rheumatologists better diagnose and treat patients
Meeting: ACR/ARHP Annual Meeting 2012: Rheumatologists Take Proactive Approach in Talking with Teen Patients about Risky Behavior
With teenaged juvenile arthritis patients, it's important for rheumatologists to engage in conversations about how drugs, tobacco, alcohol, and sex will affect them
Meeting: ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines
People with rheumatic diseases can be considered to receive flu and pneumococcal vaccines even if they're on immunosuppressive drugs
Meeting: ACR/ARHP Annual Meeting 2012: New Research Into Stem Cell Therapy and Drugs May Lead to Breakthrough Treatments for Osteoarthritis
Novel strategies for treating osteoarthritis aim to relieve pain, rebuild or replenish deteriorated cartilage and bone, or to replace the joint through surgery
Meeting: ACR/ARHP Annual Meeting 2012: Cyclophosphamide and Rituximab Both Viable Treatment Options for ANCA-Associated Vasculitis
Rituximab established as the drug of choice in patients with severe disease relapse, though cyclophosphamide may still play an important role for some patients, say rheumatologists
Meeting: ACR/ARHP Annual Meeting 2012: Early Signs of Rheumatoid Arthritis May Appear Outside the Joints
Evidence that suggests rheumatoid arthritis (RA) starts in mucosal sites such as the oral cavity and lung may lead to improved treatment and prevention of the disease
